Jiangsu Hualan Hits Day High with Strong 3.79% Intraday Surge

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. has experienced a notable increase of 3.79% on March 20, 2026, reaching an intraday high of CNY 91.80. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.24% on the same day. Over the past week, Jiangsu Hualan has shown a 3.18% gain, while its one-month performance reflects a significant increase of 10.5%. Impressively, the stock has surged by 279.65% over the past year, far outpacing the China Shanghai Composite's 16.08% growth. Year-to-date, the stock has risen by 71.62%, showcasing its strong performance relative to the market. Despite these gains, the company faces challenges, including a low Return on Capital Employed (ROCE) of 9.64% and a decline in net sales over the past five years. The current market capitalization stands at CNY 12,456 million, with a Price-to-Earnings (P/E) ratio of 151.00. As Jiangsu Hualan continues to navigate its financial landscape, its recent stock activity highlights the complexities of its market position.